DatchenFritzTaiMD

PubMed

• 31 citations
  The Patient Experience with Soft Tissue Sarcoma: A Systematic Review of the Literature
  Randall Winnette, Lisa M. Hess, Steven J. Nicol, Datchen Fritz Tai, Catherine Copley-Merriman> ;The Patient. 2017 Apr 1
• 35 citations
  Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma
  Noopur Raje, Philippe Moreau, Evangelos Terpos, Lotfi Benboubker, Norbert Grząśko, Sarah A. Holstein, Albert Oriol, Shang-Yi Huang, Meral Beksac, Kazimierz Kuliczkowsk...> ;British Journal of Haematology. 2017 Mar 1
• An innovative, multi-arm, complete phase 1b study of the novel anti-cancer agent tasisulam in patients with advanced solid tumors.
  Jotte, R. M.,Von Hoff, D. D.,Braiteh, F.,Becerra, C. R.,Richards, D. A.,Smith, D. A.,Garbo, L.,Stephenson, J.,Conkling, P. R.,Robert-Vizcarrondo, F.,Chen, J.,Turner, P...> ;Invest New Drugs. 2014 Sep 28
• 7 citations
  Phase 2 randomized study of enzastaurin (LY317615) for lung cancer prevention in former smokers.
  Jhanelle E. Gray, Soner Altiok, Mark G. Alexandrow, Frank Walsh, Jian Chen, Michael J. Schell, Datchen Fritz Tai, Gerold Bepler> ;Cancer. 2013 Mar 1
• 4 citations
  Phase II study of gemcitabine and bevacizumab as first-line treatment in taxane-pretreated, HER2-negative, locally recurrent or metastatic breast cancer.
  Rachel Borson, Graydon Harker, James Reeves, Thaddeus Beck, Steven Hager, William Horvath, Michael Jones, Guy Tillinghast, Edward Arrowsmith, Grant Harrer, Fred J. Kud...> ;Clinical Breast Cancer. 2012 Oct 1
• 19 citations
  Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer.
  Alan N. Gordon, Michael Teneriello, Mike F. Janicek, Jeffrey F. Hines, Peter Lim, M. Dwight Chen, Luis Vaccarello, Howard D. Homesley, Scott McMeekin, Tiana L. Burkhol...> ;Gynecologic Oncology. 2011 Dec 1
• 11 citations
  Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer
  Donald A. Richards, David M. Loesch, Svetislava J. Vukelja, Hillary H. Wu, William J. Hyman, Jeffery Nieves, Yunfei Wang, Simin Hu, Oluwatoyin O. Shonukan, Datchen F. Tai> ;Investigational New Drugs. 2011 Oct 1
• 3 citations
  Fixed-dose rate gemcitabine plus carboplatin in relapsed, platinum-sensitive ovarian cancer patients: Results of a three-arm Phase I study
  Ronald D. Alvarez, Robert S. Mannel, Agustin A. Garcia, Holly H. Gallion, Joseph A. Lucci, Larry C. Kilgore, T. M. Numnum, Sharon Xiaohan Zou, Mauro Orlando, Datchen F...> ;Gynecologic Oncology. 2009 Dec 1
• Phase I study of pemetrexed (P) and pegylated liposomal doxorubicin (PLD) in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer.
  Richards DA, Loesch D, Vukelja SJ, Wu HH, Hyman WJ, Nieves J, Wang Y, Hu S, Shonukan O, Tai D> ;J. Clin. Oncol.. 2009-05-20
• Phase III trial of induction gemcitabine (G) or paclitaxel (T) plus carboplatin (C) followed by elective T consolidation in advanced ovarian cancer (OC): Interim analy...
  Gordon AN, Teneriello MG, Spirtos N, Janicek MF, Goss T, Wang Y, Orlando M, Obasaju CK, Gill JF, Tai DF> ;J. Clin. Oncol.. 2008-05-20
• Interferon-alpha2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma.
  Dillman RO, Shea WM, Tai DF, Mahdavi K, Barth NM, Kharkar BR, Poor MM, Church CK, DePriest C> ;Neuro-oncology. 2001-01-01
• 5 citations
  High-Activity 125I Interstitial Irradiation in the Treatment of Pediatric Central Nervous System Tumors: A Pilot Study
  James Fontanesi, Richard L. Heideman, Michael S. Muhlbauer, Raymond K. Mulhern, Robert A. Sanford, Edwin C. Douglass, Edward H. Kovnar, J Ochs, John F. Kuttesch, Dougl...> ;Pediatric Neurosurgery. 1995 Jan 1
• Interstitial iodine 125 and concomitant cisplatin followed by hyperfractionated external beam irradiation for malignant supratentorial glioma. Preliminary experience a...
  Fontanesi J, Clark WC, Weir A, Barry A, Kumar P, Miller A, Eddy T, Tai D, Kun LE> ;Am. J. Clin. Oncol.. 1993-10-01
• Treatment of choroidal melanoma with I-125 plaque.
  Fontanesi J, Meyer D, Xu S, Tai D> ;Int. J. Radiat. Oncol. Biol. Phys.. 1993-07-15
• Concomitant cisplatin and hyperfractionated external beam irradiation for advanced malignancy of the head and neck.
  Fontanesi J, Beckford NS, Lester EP, Kavanaugh KT, Tai D, Eddy T, Kun LE> ;Am. J. Surg.. 1991-10-01
• Phase II trial of subcutaneous interferon followed by intravenous hybrid bolus/continuous infusion interleukin-2 in the treatment of renal cell carcinoma: final result...
  Dillman, R. O., Wiemann, M. C., Tai, D. F., Depriest, C. B., Soori, G., Stark, J. J., Mahdavi, K., Church, C. K.> ;Cancer Biother Radiopharm. 2006 Apr
• 52 citations
  A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier Oncology Group study
  Higinia R. Cardenes, Annette M. Moore, Cynthia S. Johnson, Menggang Yu, Paul R. Helft, Elena G. Chiorean, Jacob Vinson, Thomas J. Howard, Anthony W. Stephens, D. Fritz...> ;American Journal of Clinical Oncology. 2011 Oct 1
• A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer.
  Hensley, M. L., Larkin, J., Fury, M., Gerst, S., Tai, D. F., Sabbatini, P., Konner, J., Orlando, M., Goss, T. L., Aghajanian, C. A.> ;Clin Cancer Res. 2008 Oct 01
• Join now to see all